Microsoft word - spa_jul_20__11.doc

Daily Newsletter 20 Jul, 2011
Morning Glance
Equity Research Desk
Market Summary
The market closed on a negative note on Tuesday. The overall market breadth was positive, around 57.2% of shares advanced on BSE and 59.4% of shares advanced on NSE. Out of the total 3,004 shares traded at BSE, 1,652 advanced, 1,219 declined, while 133 remained unchanged. After a lackluster morning trade, benchmark indices, taking cues from the positive European markets, spiked up in the afternoon and ended with decent gains. Auto stocks continued their underperformance. Key European markets were trading with gains ranging from 0.5% to 1.5%, buoyed by solid results from Novartis AG and gains in shares of technology companies. US stock futures were up about two third of a percent ahead of data on June housing starts and building permits. BSE Consumer Durable and IT indices gained the most among the sectoral indices, putting on 1.4% and 1.2% respectively while Auto and Power indices lost 0.4% and 0.3% At the close, the benchmark 30-share index, BSE Sensex gained 146.83 points or 0.79% at 18,653.87 with 24 components registering rise. Meanwhile, the broad *7.35 A.M Today
based NSE Nifty climbed by 46.50 or 0.84% at 5,613.55 with 44 components Delivery
Nifty Most Delivered
Gainers in the 30-share index were D L F (2.09%), Sterlite Industries (India)
(1.77%), Tata Power Company (1.62%), State Bank Of India (1.59%), Infosys Technologies (1.45%), and Reliance Industries (1.39%). However, Tata
Motors (3.16%), Hero Honda Motors (1.22%), Maruti Suzuki India (0.79%), H D F C Bank (0.70%), Hindustan Unilever (0.42%), and Oil & Natural Gas Corporation (0.09%) were the biggest losers in the Sensex. Nifty Least Delivered
Strong profits and a bipartisan plan to lift the U.S. debt limit drove a US stock
market rebound Tuesday. The Dow Jones industrial average gained 202.26
points, or 1.63%, to close at 12,587.42. The Nasdaq gained 61.41 points, or
Trade Statistics
Board Meeting
Total 3004
IRB Infrastructure Developers Limited Result Inst. Activity
FIIs (Rs cr) Source : SEBI
Open Interest (Rs. Cr) 89,591
MFs (Rs cr) 18-Jul
Change (pts)
10,775 12,014
3,179,509 89,591
Daily Newsletter 20 Jul, 2011
Morning Glance
Equity Research Desk
Junior Nifty Delivery Statistics for 19th Jul 2011

ABB wins USD 15 mn water order in Saudi Arabia
Traded Qty
Power and automation technology group ABB has won an order worth about USD 15 mil ion from Japanese pump manufacturer, Torishima Pump, to provide a turnkey electrical control and instrumentation solution for a new pumping station under construction in Saudi Arabia. NIIT Tech Q1 cons profit up marginally
NIIT Technologies has posted a consolidated net profit of Rs 412 million for the quarter ended June 30, 2011 as compared to Rs 408 mil ion for the quarter ended June 30, 2010, representing increase of 0.8%. Total Income has increased from Rs 2,914 mil ion for the quarter ended June 30, 2010 to Rs 3,288 million for the quarter ended June 30, 2011, representing increase of 12.83% Supreme Petrochem FY11 profit jumps 45%
Supreme Petrochem (SPL), a styrenics major and the largest polystyrene
Derivatives Watch
producer in India has posted a net profit of Rs 876.9 million for the year ended June 30, 2011 as compared to Rs 604.7 mil ion for the year ended June 30, Nifty OI PCR at 1.20 as against 1.25 on Tuesday
2010 representing rise of 45.01%. Net revenues for the year 10-11 stood at Rs Nifty up 0.84%; Futures OI up 0.93%
19.43 billion as compared to Rs 16.11 billion in the preceding year. Nifty Jul. futures trading at 5.45 points Premium
Cadila Q1 cons net grows 15.6%
Commodity Update
Pharmaceutical company Cadila Healthcare has posted growth of 15.58% in its consolidated net profit at Rs 2.30 billion for the quarter ended June 30, 2011 as Asian stocks rose, with the regional benchmark index set to
against Rs 1.99 billion for the corresponding quarter a year ago. Total income of close at its highest level in a week, on optimism U.S. lawmakers the company on consolidated basis has increased by 10.11% at Rs 12.52 bil ion wil reach an agreement to cut the budget deficit and after Apple for June quarter as against Rs 11.37 billion for the corresponding quarter a year Inc.`s profit topped estimates, boosting the earnings outlook for exporters. Japanese benchmark index Nikkei 225 rose 141.34 points, or 1.43%, to trade at 10,031.10. Hong Kong`s Hang Sun Pharma gets USFDA nod for Uroxatral ER
Seng index advanced by 170.49 points, or 0.78%, at 22,072.90. Sun Pharmaceuticals Industries announced that USFDA has granted its South Korea`s Kospi index increased 24.37 points, or 1.14% to subsidiary an approval for its abbreviated new drug Application (ANDA) to market a generic version of Uroxatral ER, alfuzosin hydrochloride extended release tablets. Sun Pharma, being the first to file an ANDA for generic version Oil prices reversed direction again Tuesday, rising 2% as
of Uroxatral ER with a para IV certification, received a 180 days marketing traders took their cues from the dol ar and stock markets. Brent crude, which is used to price many international oil varieties, gained USD 1.01 to settle at USD 117.06 a barrel on the ICE Shilpa Medicare acquires controlling stake in Nu Therapeutics
Shilpa Medicare had invested in Nu Therapeutics (P), (NU) initially in the last year and now acquired controlling stake. NU is established by the Technocrats In the commodity space, MCXCOMDEX was up on Tuesday
for manufacturing of oral fast dissolving thin strip dosage jointly with others. 0.77% to 3,538.44 points, MCX Metal index was up by 0.31% to 4,738.44 points and MCX Energy index was up by 1.04% to Thomas Cook to offer training course to TIRUN Travel
Thomas Cook (India), the integrated travel and travel related financial services company in India, has signed a one-of-its kind agreement with TIRUN Travel Bullion: Gold August 11 contract was down by 0.20% to Rs
Marketing to offer a unique online training course certified by Royal Caribbean 23,181 per 10 grams, GoldM August 11 contract was down by 0.20% to Rs 23,184 per 10 grams, Gold guinea July 11 contract was down by 0.16% to Rs 18,570 per 8 grams and Gold Petal Indowind Energy inks power sale pact with Apollo Hospitals
July 11 contract was down by 0.17% to Rs 2,328 per gram. Indowind Energy has successfully completed the power sale agreement with Silver September 11 contract was up by 0.04% to Rs 59,895 per Apollo Hospitals Enterprise, for supply of 10 million units per annum under kg, SilverM August 11 contract was up by 0.03% to Rs 59,901 Group Captive` scheme through its subsidiary Indowind Power. This strategic per kg and SilverMIC August 11 contract was up by 0.02% to Rs tie-up shall give long term benefit to the companies. The stock had 59,907 per kg. Metals: Lead July 11 contract was up by 0.91%
outperformed the market over the past one month till Jul. 18, 2011, rising 69.52% compared with the Sensex`s 3.56% rise. Major BSE Bulk Deals
Scrip Name
Client Name
Deal Type
Major NSE Bulk Deals
Scrip Name
Client Name
Deal Type
Daily Newsletter 20 Jul, 2011
Morning Glance
Equity Research Desk

: This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. SPA Securities Limited (hereinafter referred
as SPA) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any
other person in any form. This document is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The intent of this document is not in
recommendary nature. The views expressed are those of analyst and the Company may or may not subscribe to all the views expressed therein The report is based upon information that we consider
reliable, but we do not represent that it is accurate or complete, and it should not be relied upon such. SPA or any of its affiliates or employees shall not be in any way responsible for any loss or damage
that may arise to any person from any inadvertent error in the information contained in this report. Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages
whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. SPA or any of its affiliates or
employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of
merchantability, fitness for a particular purpose, and non-infringement.
The recipients of this report should rely on their own investigations. SPA and/or its affiliates and/or employees may have interests/ positions, financial or otherwise in the securities mentioned in this
report. SPA has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report.
This information is subject to change without any prior notice. SPA reserves the right to make modifications and alternations to this statement as may be required from time to time. Nevertheless, SPA is
committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries.
SPA Securities Limited
SPA House, Nyay Sagar, Near Gurunanak Hospital, Bandra (E), Mumbai - 400051, Tel. No. : +91-22-4289 5000
For More Information Visit Us At SPA Securities Ltd.
Member of NCDEX & MCX. NCDEX TMID- LTD. Direct Broker for Life and General Insurance DP – CDSL


DISCIPLINA: QUIMICA FARMACEUTICA PLANO DE ENSINO OBJETIVOS: • Reconhecer os fármacos de origem sintética e semi-sintética, constantes das últimas edições de farmacopéias e outros códigos farmacêuticos. • Aplicar conhecimentos visando a obtenção de fármacos e seus análogos. • Identificar as relações estruturais e atividades farmacológicas existentes nas as clas

Myria Christophini Selected Exhibitions  2011: Bealtainne, The Glue Factory, Glasgow (30 April-14 May 2011).  2010: Half-knowledge/half., Grace and Clark Fyfe Gallery, Glasgow(12-28  2007: If it is to be, The BRIDGE Gallery, London (07-12 September 2007).  2007: Out of Nothing, Canterbury Environment Centre, Canterbury(01-10 May  2005: Transmission: Laurence Rathsack, Liz B

Copyright © 2018 Medical Abstracts